QuackeryWatch Canadian Quackbusting Since 1998 · Dr. Terry Polevoy MD

Full Investigation · Kitchener, Penticton & Abroad · 1996–2005

Zoetron / CSCT: Electromagnetic Cancer Fraud, Run from Kitchener and Penticton

A Canadian company sold cancer patients a magnetic “therapy” it said killed cancer cells and spared healthy ones, at clinics in four countries, for up to US$20,000 a course. More than 850 people paid. The U.S. Federal Trade Commission shut it down in 2003. In 2005 Canada's Competition Bureau laid criminal charges against the two men who ran it.

By Terry Polevoy, MD · QuackeryWatch.com · First published 2006; rebuilt and corrected October 2026
Correction. Earlier versions of this page said that no one was criminally charged over CSCT. That was true in the United States but not in Canada: the Competition Bureau charged both principals in 2005. The page has been corrected. The outcome of those charges has not yet been found.

What was sold

CSCT told cancer patients that its device used a magnetic field to find and destroy cancer cells while leaving healthy tissue alone, with none of the damage of chemotherapy or radiation. No clinical trial supported any of it. The company advertised through its website, at seminars, in alternative-health magazines, by direct mail and by telephone, and directed patients to its clinics abroad, where the treatment was given over several weeks. Patients paid US$15,000 or more up front.

The Kitchener office

For an operation with clinics on three continents, the head office was small. CSCT set up in Kitchener in early 1998, first in a commercial plaza on Victoria Street North and later in a downtown office building at King Street West and Water Street. Patients' bookings and payments were handled there: someone who wanted treatment arranged it through the Kitchener office, which sent them to a clinic in the Dominican Republic, Mexico or Europe. Armstrong, originally from the United States, lived in the area and worked in the office, which a Bureau investigator described as probably a one- or two-person operation; Reynolds lived in Toronto. In mid-2001 Armstrong moved the company to Penticton, B.C., and ran it from his home.

The Bureau's Ontario-region supervisor on the case, Mark Stainsby, told the Record in 2005 that experts who examined the equipment found it could do none of what was claimed, and that he doubted many of the patients were still alive. The FTC alleged that some patients died after giving up conventional cancer treatment for the device.

The shutdown, February 2003

The operation was closed in a single coordinated sweep. Canada's Competition Bureau executed search warrants in Ontario and British Columbia. The U.S. Federal Trade Commission, acting with Canadian and Mexican officials, obtained a temporary restraining order in the Northern District of Illinois that suspended CSCT's domain name and froze its American bank accounts; a preliminary injunction followed on 21 February 2003. Mexican health authorities closed the last clinic, in Tijuana.

The San Diego Union-Tribune reported the Tijuana end the same day. Mexican federal health inspectors swept through CSCT's sixth-floor offices in the city's Río Zone the week before and closed the clinic for offering an unapproved treatment. Staff would not come to the door that afternoon; by the next day a metal shutter had been pulled down over it. “We are taking action … so that all units that offer health services follow federal health standards,” said Francisco Vera, Baja California's health secretary, whose department took part. According to the FTC, patients wired US$15,000 to CSCT's Canadian office and then spent up to eight weeks at the Tijuana clinic; by the time some left, their cancer had advanced so far that other treatment could no longer help. The clinic had moved to Tijuana from the Dominican Republic in 1998. The three governments coordinated the action through the Mexico–U.S.–Canada Health Fraud Work Group. “This case and other cooperative efforts with Canada and Mexico will show fraudulent operators that they will not be able to evade law enforcement by operating in one country and targeting consumers of another,” said Howard Beales, director of the FTC's Bureau of Consumer Protection.

The Record reported the shutdown in Kitchener on 21 February 2003. A Competition Bureau assistant deputy commissioner told reporters that about 10 per cent of the patients were Canadian. The U.S. Food and Drug Administration's commissioner, Mark McClellan, said the treatment had led some patients to delay therapies that might have saved their lives.

The American settlement, February 2004

CSCT, Armstrong and Reynolds settled the FTC case by a stipulated final judgment filed on 12 February 2004. They were permanently barred from offering Zoetron therapy, from claiming any treatment kills cancer cells or affects tumours, and from making any health claim without competent scientific evidence, and from selling their customer lists. A judgment of $7.65 million was entered against them jointly — and suspended, to be revived only if a court found they had misrepresented their finances. They did not have to admit wrongdoing.

When this page was first written, that was all there was to report, and it read like a pass: the websites gone, the money frozen in the United States, and nothing for the Canadians who had paid.

The Canadian charges, August 2005

On 2 August 2005 the Competition Bureau announced charges against Reynolds and Armstrong: ten counts each under the Competition Act of knowingly or recklessly making false or misleading representations to the public, and one count each under the Criminal Code of defrauding the public of more than $5,000. The Bureau's deputy commissioner said the false hope given to cancer patients was a greater concern than the money they lost.

The case was built by the Toronto Strategic Partnership — Toronto Police, Ontario Provincial Police, York Regional Police, the RCMP and Ontario's consumer ministry, working with the FTC, the U.S. Postal Inspection Service and Britain's Office of Fair Trading — with help from police in Switzerland, Belgium and Spain. It is the only criminal prosecution over cancer-cure claims that this site has found the Bureau bringing.

No report of the outcome — trial, plea, conviction, stay or withdrawal — has been found. The Bureau does not appear to have announced one. That gap is the subject of Project False Hope, the Bureau's 2008 cancer-fraud initiative, which promised enforcement and produced none that can be found.

The European trail

Tijuana is the clinic most people remember, but the European side of the operation left its own records.

The Swiss clinic

In Switzerland the treatment was sold by CSCT Suisse S.A., also styled the Zentrum für zellspezifische Krebstherapie (Centre for Cell-Specific Cancer Therapy). German- and Dutch-language sources place it in Yverdon-les-Bains, a spa town about 35 km north of Lausanne. Fees matched the North American ones, US$15,000 to $20,000. Patients lay on a table inside the ring-shaped device, which was also sold under the name “CSCT 200.” The Swiss company has since closed.

A Dutch government report

The Dutch Health Care Inspectorate (Inspectie voor de Gezondheidszorg, IGZ) published a report titled De zorgverlening aan S.M. (“The care given to S.M.”). It records that the patient was given cell specific cancer therapy, or Zoetron therapy, at the clinic in Yverdon. It may be the only official government document anywhere that records a named Zoetron patient's care. QuackeryWatch is trying to obtain the full report.

Still listed after the ban

The February 2004 FTC order permanently barred CSCT and both principals from promoting Zoetron therapy. Even so, a review of electromagnetic cancer therapies, posted online years later, still listed “Zoetron Therapy, www.csct.com” among treatments on offer in Europe and North America, with no mention that U.S. regulators had called it a sham. Archived copies of csct.com survive on the Internet Archive's Wayback Machine.

Where are the machines?

No Zoetron or CSCT 200 unit has been found offered for sale today, and there is no public record of what happened to the devices after the Tijuana, Swiss and Spanish clinics closed.

Open questions

In October 2026 QuackeryWatch wrote to the Commissioner of Competition asking how the charges ended, and filed an Access to Information request for the file. The answer will be reported here. A search of Ontario and British Columbia court records could also answer the first question. The full names and ages help: John Leslie Armstrong, born about 1945, of Penticton, for British Columbia's Court Services Online; and Michael John Reynolds, born about 1944, of Toronto, for the Ontario Court of Justice. Readers with knowledge of the case are invited to write.

Related on QuackeryWatch

Support this work

QuackeryWatch is free, independent and reader-supported

No ads, no sponsors, no industry money. If this investigation was useful to you, here are two ways to keep the work going.

As an Amazon Associate, QuackeryWatch earns from qualifying purchases. It costs you nothing extra and never affects what we write.

Sources

  1. Competition Bureau. “Criminal charges laid in cancer treatment scam following Competition Bureau investigation.” 2 August 2005.
  2. FTC v. CSCT, Inc., CSCT, Ltd., John Leslie Armstrong and Michael John Reynolds, Civ. No. 03 C 00880 (N.D. Ill.). Stipulated Final Judgment and Order, filed 12 February 2004.
  3. Federal Trade Commission. “CSCT, Inc. settles FTC charges.” Press release, February 2004; and the 2003 joint FTC–Canada–Mexico release announcing the case.
  4. Brian Caldwell. “Cancer scam's local roots” (continued as “Cancer: Therapy bogus”). Waterloo Region Record, 6 August 2005, pp. A1 and A2. Viewed via Newspapers.com.
  5. Waterloo Region Record, report on the FTC and Competition Bureau action against CSCT, 21 February 2003. Viewed via Newspapers.com.
  6. Sandra Dibble. “Cancer clinic in Tijuana closed, sued by the FTC.” San Diego Union-Tribune, 21 February 2003.
  7. Trilateral Cooperation Charter (United States, Canada, Mexico), in effect 1 March 2004.
  8. Psiram. “Cell Specific Cancer Therapy” (German). On CSCT Suisse S.A., Yverdon-les-Bains, and the CSCT 200 device.
  9. Skepsis (Netherlands). “Zoetron” (Dutch). Quotes the IGZ report De zorgverlening aan S.M.
  10. “A Review of Cancer Electromagnetic Frequency Therapy: Towards Physics of Cancer.” ResearchGate, appendix listing Zoetron Therapy.

Charges are not convictions. No outcome of the 2005 Canadian charges has been located, and this page does not suggest one. Corrections are welcome and are recorded on the page.